[PDF] from medpagetoday.comO Adeoye, R Hornung, P Khatri… - Stroke, 2011 - Am Heart Assoc Results—Within Medicare Provider and Analysis Review, thrombolytic use increased from 1.1% in 2005 to 3.4% in 2009 (P<0.001 for trend). Within Premier, thrombolytic use increased from 1.4% in 2005 to 3.7% in 2009 for all cases (P<0.001). Analysis of pharmacy billing ... Related articles - All 4 versions
J Minnerup, H Wersching, EB Ringelstein… - Stroke, 2011 - Am Heart Assoc Results—Overall, 9262 patients (10.1%) were treated with recombinant tissue-type plasminogen activator. The proportion of thrombolyzed patients increased from 8.6% in 2007 to 11.7% in 2009. This increase was pronounced for patients admitted between 3 and 6 hours after ...
C Gakuba, M Gauberti, M Mazighi, G Defer… - Stroke, 2011 - Am Heart Assoc Arecent controversy has emerged in the field of endovas- cular treatment for stroke.1 Tremendous efforts have been made in the past decade to design the optimal protocol in interventional radiology to recanalize occluded arteries. Para- doxically, there is no prospective study conducted ...
VJ Marder, A Blinc, T Gruber, G Tratar, M Sabovic… - Stroke, 2011 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters ... Comparison of Plasmin With Recombinant Tissue-Type Related articles - All 3 versions
N Naff, MA Williams, PM Keyl, S Tuhrim… - Stroke, 2011 - Am Heart Assoc From the Sandra and Malcolm Berman Brain & Spine Institute (NN), Department of Neurosurgery, Sinai Hospital of Baltimore, Baltimore, MD; Departments of Neurosurgery and Neurology (NN, PMK, WCZ, NM, KL, DFH), Johns Hopkins University School of Medicine, ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
